28359664|t|Omega 3 Fatty Acids Reduce Bone Resorption While Promoting Bone Generation in Rat Apical Periodontitis
28359664|a|This study evaluated the effects of the dietary supplement omega 3 polyunsaturated fatty acids (ω-3 PUFAs) on pulp exposure -induced apical periodontitis (AP) in rats. Twenty-eight male rats were divided into groups: control untreated rats (C), control rats treated with ω-3 PUFAs alone (C-O), rats with pulp exposure -induced AP, and rats with pulp exposure -induced AP treated with ω-3 PUFAs (AP -O). The ω-3 PUFAs were administered orally, once a day, for 15 days before pulp exposure and, subsequently, 30 days after pulp exposure. Rats were killed 30 days after pulp exposure, and jaws were subjected to histologic and immunohistochemical analyses. Immunohistochemical analyses were performed to detect tartrate-resistant acid phosphatase - positive osteoclasts and osteocalcin - positive osteoblasts on the bone surface of periapical area. Results were statistically evaluated by using analysis of variance and Tukey honestly significant difference, and P < .05 was considered statistically significant. The bone resorption lesion was significantly larger in the AP group compared with AP -O, C, and C-O groups (P < .05). The level of inflammatory cell infiltration was significantly elevated, and the number of tartrate-resistant acid phosphatase - positive osteoclasts was significantly higher in the periapical lesions of the AP group compared with AP -O, C, and C-O groups (P < .05). The number of osteocalcin - positive osteoblasts was significantly increased in the AP -O group compared with the AP group (P > .05). Supplementation with ω-3 PUFAs not only suppresses bone resorption but also promotes new bone formation in the periapical area of rats with AP in conjunction with downregulation of inflammatory cell infiltration into the lesion.
28359664	0	19	Omega 3 Fatty Acids	T103	UMLS:C0015689
28359664	27	42	Bone Resorption	T038	UMLS:C0005974
28359664	49	74	Promoting Bone Generation	T038	UMLS:C1371285
28359664	78	81	Rat	T204	UMLS:C0034721
28359664	82	102	Apical Periodontitis	T038	UMLS:C0031030
28359664	114	123	evaluated	T058	UMLS:C0220825
28359664	143	161	dietary supplement	T168	UMLS:C0242295
28359664	162	197	omega 3 polyunsaturated fatty acids	T103	UMLS:C0015689
28359664	199	208	ω-3 PUFAs	T103	UMLS:C0015689
28359664	213	226	pulp exposure	T038	UMLS:C0011406
28359664	236	256	apical periodontitis	T038	UMLS:C0031030
28359664	258	260	AP	T038	UMLS:C0031030
28359664	265	269	rats	T204	UMLS:C0034721
28359664	289	293	rats	T204	UMLS:C0034721
28359664	312	318	groups	T098	UMLS:C1257890
28359664	328	337	untreated	T033	UMLS:C0332155
28359664	338	342	rats	T204	UMLS:C0034721
28359664	356	360	rats	T204	UMLS:C0034721
28359664	374	383	ω-3 PUFAs	T103	UMLS:C0015689
28359664	397	401	rats	T204	UMLS:C0034721
28359664	407	420	pulp exposure	T038	UMLS:C0011406
28359664	430	432	AP	T038	UMLS:C0031030
28359664	438	442	rats	T204	UMLS:C0034721
28359664	448	461	pulp exposure	T038	UMLS:C0011406
28359664	471	473	AP	T038	UMLS:C0031030
28359664	487	496	ω-3 PUFAs	T103	UMLS:C0015689
28359664	498	500	AP	T038	UMLS:C0031030
28359664	510	519	ω-3 PUFAs	T103	UMLS:C0015689
28359664	525	544	administered orally	T058	UMLS:C0001563
28359664	577	590	pulp exposure	T038	UMLS:C0011406
28359664	624	637	pulp exposure	T038	UMLS:C0011406
28359664	639	643	Rats	T204	UMLS:C0034721
28359664	670	683	pulp exposure	T038	UMLS:C0011406
28359664	689	693	jaws	T017	UMLS:C0022359
28359664	747	755	analyses	T062	UMLS:C0936012
28359664	777	785	analyses	T062	UMLS:C0936012
28359664	811	846	tartrate-resistant acid phosphatase	T103	UMLS:C0297331
28359664	849	857	positive	T033	UMLS:C1446409
28359664	858	869	osteoclasts	T017	UMLS:C0029431
28359664	874	885	osteocalcin	T103	UMLS:C0029419
28359664	888	896	positive	T033	UMLS:C1446409
28359664	897	908	osteoblasts	T017	UMLS:C0029418
28359664	916	928	bone surface	T082	UMLS:C0825429
28359664	932	947	periapical area	T082	UMLS:C0729269
28359664	976	985	evaluated	T058	UMLS:C0220825
28359664	1117	1132	bone resorption	T038	UMLS:C0005974
28359664	1133	1139	lesion	T033	UMLS:C0221198
28359664	1172	1174	AP	T038	UMLS:C0031030
28359664	1195	1197	AP	T038	UMLS:C0031030
28359664	1213	1219	groups	T098	UMLS:C1257890
28359664	1244	1274	inflammatory cell infiltration	T038	UMLS:C0302158
28359664	1321	1356	tartrate-resistant acid phosphatase	T103	UMLS:C0297331
28359664	1359	1367	positive	T033	UMLS:C1446409
28359664	1368	1379	osteoclasts	T017	UMLS:C0029431
28359664	1412	1422	periapical	T082	UMLS:C0729269
28359664	1423	1430	lesions	T033	UMLS:C0221198
28359664	1438	1440	AP	T038	UMLS:C0031030
28359664	1461	1463	AP	T038	UMLS:C0031030
28359664	1479	1485	groups	T098	UMLS:C1257890
28359664	1511	1522	osteocalcin	T103	UMLS:C0029419
28359664	1525	1533	positive	T033	UMLS:C1446409
28359664	1534	1545	osteoblasts	T017	UMLS:C0029418
28359664	1581	1583	AP	T038	UMLS:C0031030
28359664	1611	1613	AP	T038	UMLS:C0031030
28359664	1631	1646	Supplementation	T058	UMLS:C0242297
28359664	1652	1661	ω-3 PUFAs	T103	UMLS:C0015689
28359664	1682	1697	bone resorption	T038	UMLS:C0005974
28359664	1707	1734	promotes new bone formation	T038	UMLS:C1371285
28359664	1742	1757	periapical area	T082	UMLS:C0729269
28359664	1761	1765	rats	T204	UMLS:C0034721
28359664	1771	1773	AP	T038	UMLS:C0031030
28359664	1794	1808	downregulation	T038	UMLS:C0013081
28359664	1812	1842	inflammatory cell infiltration	T038	UMLS:C0302158
28359664	1852	1858	lesion	T033	UMLS:C0221198